Strategic Initiative
Slingshot members are tracking this corporate initiative:
Cellectis (CLLS) Announces Increase in Production of UCART123 T-Cell Therapy Candidate for Acute Myeloid Leukemia (AML) and Other Cancers
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLLS |
|
|
||||
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 16, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2017
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Ucart123, T-cell Therapy Candidate, Acute Myeloid Leukemia, Aml, Other Cancers, Increase In Production
